Thursday, April 22, 2010

Codexis Prices IPO

Redwood City-based Codexis, a developer of biocatalysts for the pharmaceutical and biofuels industries, said today that it has priced its IPO at $13.00 a share. The firm is selling 6,000,000 shares of its common stock on the NASDAQ Global Market as CDXS. The firm's IPO is being underwritten by Credit Suisse, Piper Jaffray & Co., RBC Capital Markets, and Pacific Crest Securities. Codexis is backed by Maxygen Inc, Shell Oil, Biomedical Sciences Investment Fund, CMEA Ventures, FirstMark Capital, and CTTV Investments, among others.